Drug intelligence / Profile preview

Jessner's solution

Development stage
Phase 2
Lead developer
Max Jessner
Modality
Small Molecules
Administration
Topical
01

Overview

Jessner's solution is a classic superficial-to-medium depth chemical peeling agent widely used in dermatology for the treatment of various skin conditions, including hyperpigmentation, acne, and photoaging. The traditional formulation, developed by dermatologist Dr. Max Jessner, consists of a synergistic combination of 14% salicylic acid, 14% lactic acid, and 14% resorcinol in an ethanol base. This combination was designed to maximize efficacy while minimizing the toxicity and side effects associated with high concentrations of its individual components. A 'Modified Jessner's solution' replaces resorcinol with citric acid (often 8% citric, 17% lactic, and 17% salicylic acid) to reduce the risk of allergic reactions and post-inflammatory hyperpigmentation, particularly in patients with darker skin types (Fitzpatrick IV-VI). The solution works by inducing keratolysis and controlled epidermal necrosis, which facilitates the removal of melanin-containing keratinocytes and promotes dermal collagen remodeling. It is frequently used as a standalone treatment or in combination with other agents like trichloroacetic acid (TCA) to enhance penetration and outcomes.

Brand names
Jessner's PeelJS
Other names
Jessner solutionModified Jessner's solutionMJMJsCombe's solution

Beyond the preview

Go deeper on Jessner's solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jessner's solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call